Preparation, physicochemical characterization and biological evaluation of cefodizime metal ion complexes

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 6, 2009, Pages 753-758

  Auda, Sayed H ^a,b   Mrestani, Yahya ^a   Nies, Dietrich H ^a   Große, Cornelia ^a   Neubert, Reinhard H H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Al Azhar University   (Egypt)

Author keywords

Antibacterial activity; Cefodizime; Metal complexes; Physicochemical characterization

Indexed keywords

ALUMINUM; CEFODIZIME; COBALT; COPPER; IRON; METAL ION; ZINC; ANTIINFECTIVE AGENT; CEFOTAXIME; DRUG DERIVATIVE; HEAVY METAL;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL STRAIN; CULTURE MEDIUM; DRUG BINDING; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; ELECTRIC CONDUCTIVITY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED RADIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS VULGARIS; PSEUDOMONAS PUTIDA; RAMAN SPECTROMETRY; STOICHIOMETRY; ULTRAVIOLET RADIATION; CHEMISTRY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; INFRARED SPECTROSCOPY; MICROBIOLOGICAL EXAMINATION; ULTRAVIOLET SPECTROPHOTOMETRY;

ALUMINUM; ANTI-BACTERIAL AGENTS; CEFOTAXIME; COBALT; COPPER; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; IRON; METALS, HEAVY; MICROBIAL SENSITIVITY TESTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; ZINC;

EID: 85047681989     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.06.0007     Document Type: Article

References (27)

1. Parfitt K. Martindale. The Complete Drug Reference, 33rd edn. London: The Pharmaceutical Press, 2002: 167.
2. Kalman D, Barriere SL. Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins. Tex Heart Inst J 1990; 17: 203-215.
3. Anacona JR, Gil CC. Synthesis and antibacterial activity of cefoxitin metal complexes. Transition Met Chem 2005; 30: 605-609.
4. Anacona JR, Rodriguez A. Synthesis and antibacterial activity of ceftriaxone metal complexes. Transition Met Chem 2005; 30: 897-901.
5. Bryskier A et al. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g. J Antimicrob Chemother 1990; 26: 59-63.
6. Lenfant B et al. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers. Antimicrob Agents Chemother 1995; 39: 2037-2041.
7. Aly AAM et al. Thermal and photochemical behavior of Zn(II) complexes of some cephalosporins. J Thermal Anal Calorim 2004; 75: 159-168.
8. Andersen O. Principles and recent developments in chelation treatment of metal intoxication. Chem Rev 1999; 99: 2683-2710.
9. Liu ZD, Hider RC. Design of iron chelators with therapeutic application. Coord Chem Rev 2002; 232: 151-172.
10. Macdonald JS, Astrow AB. Adjuvant therapy of colon cancer. Semin Oncol 2001; 28: 30-40.
11. Pelley RJ. Oxaliplatin: a new agent for colorectal cancer. Curr Oncol Rep 2001; 3: 147-155.
12. Briand GG, Burford N. Coordination complexes of bismuth(III) involving organic ligands with pnictogen and chalcogen donors. Adv Inorg Chem 2000; 50: 285-357.
13. Sanchez-Delgado RA et al. Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium-and rhodium-chloroquine complexes. J Med Chem 1996; 39: 1095-1099.
14. Navarro M et al. Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au (PPh3)(CQ)]PF6. J Med Chem 1997; 40: 1937-1939.
15. Iqbal MS et al. Preparation, characterization and biological evaluation of copper(II) and zinc(II) complexes with cephalexin. J Pharm Pharmacol 1999; 51: 371-375.
16. Jackson GE et al. Metal ligand complexes involved in rheumatoid arthritis - VII, formation of binary and ternary complexes between 2,3-diaminopropioic acid, histidine and Cu(II), Ni(II) and Zn(II). J Inorg Nucl Chem 1981; 43: 825-829.
17. Nagar R, Mohan G. Synthetic and pharmacological studies on some transition metal chelates involving N-pyrimidino benzamide-2-carboxylic acid as ligand. J Inorg Biochem1991; 42: 9-16.
18. Auda SH et al. Characterization and activity of cephalosporin metal complexes. Pharmazie 2008; 63: 555-561.
19. Silverstein RM et al. Spectrometric Identification of Organic Compounds, 5th edn. New York: John Wiley & Sons, 1991: 118.
20. Anacona JR, Gil CC. Synthesis and antibacterial activity of cefixime metal complexes. Transition Met Chem 2006; 31: 227-231.
21. Gang Z, Yuan C. Synthesis and physicochemical studies on S-methyl-β-N-(ferrocenyl)methylenedithiocarbazate and its rare earth complexes. Transition Met Chem 1994; 19: 218-220.
22. Zayed MA, Abdallah SM. Synthesis, characterization and electronic spectra of cefadroxil complexes of d-block elements. Spectrochim Acta A Mol Biomol Spectrosc 2004; 60: 2215-2224.
23. Eboka CJ, Okeri HA. Aqueous solubility of ciprofloxacin in the presence of metal cations. Trop J Pharm Res 2005; 4: 349-354.
24. Anacona JR, Acosta F. Synthesis and antibacterial activity of cephradine metal complexes. J Coord Chem 2005; 59: 621-627.
25. Jones RN et al. In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin. Antimicrob Agents Chemother 1981; 20: 760-768.
26. Anacona J, Estacio J. Synthesis and antibacterial activity of cefixime metal complexes. Transition Met Chem 2006; 31: 227-231.
27. Chohan ZH. Synthesis of cobalt(II) and nickel(II) complexes of Ceclor (Cefaclor) and preliminary experiments on their antibacterial character. Chem Pharm Bull 1991; 39: 1578-1580.